interestingly, ezh2 associated mirnas were predicted to target 25 genes in glioma-pathway, suggesting their role in tumor formation or progression.
Our work suggests EZH2 and its miRNA interactors may serve as promising biomarkers for progression of astrocytic tumors and may offer novel therapeutic strategies.